Eye (Lond). 2017 Jun;31(6):828-845. doi: 10.1038/eye.2016.298. Epub 2017 Mar 10.
PMID:28282061
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation.
Sharrock AV, Mulligan TS, Hall KR, Williams EM, White DT, Zhang L, Emmerich K, Matthews F, Nimmagadda S, Washington S, Le KD, Meir-Levi D, Cox OL, Saxena MT, Calof AL, Lopez-Burks ME, Lander AD, Ding D, Ji H, Ackerley DF, Mumm JS.
Nat Methods. 2022 Feb;19(2):205-215. doi: 10.1038/s41592-021-01364-4. Epub 2022 Feb 7.
PMID:35132245
Coccidioidomycosis Chorioretinitis.
Nordstrom B, Sherpa N, Marshall M, Chawla A, Heidari A, Johnson R.
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619881561. doi: 10.1177/2324709619881561.
PMID:31597500
Disseminated nontuberculous mycobacterial infection with multifocal retinitis and vasculitis in an immunocompromised patient with anti-IFN- autoantibodies.
Lee TL, Agrawal R, Tan JY, Ong KH, Wong CS, Ho SL.